These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22178578)

  • 1. Thrombomodulin is required for the antithrombotic activity of thrombin mutant W215A/E217A in a mouse model of arterial thrombosis.
    Vicente CP; Weiler H; Di Cera E; Tollefsen DM
    Thromb Res; 2012 Oct; 130(4):646-8. PubMed ID: 22178578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Thrombomodulin Enables W215A/E217A Thrombin to Cleave Protein C but Not Fibrinogen.
    Peacock RB; McGrann T; Zaragoza S; Komives EA
    Biochemistry; 2022 Jan; 61(2):77-84. PubMed ID: 34978431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional thrombomodulin deficiency causes enhanced thrombus growth in a murine model of carotid artery thrombosis.
    Dörffler-Melly J; de Kruif M; Schwarte LA; Franco RF; Florquin S; Spek CA; Ince C; Reitsma PH; ten Cate H
    Basic Res Cardiol; 2003 Nov; 98(6):347-52. PubMed ID: 14556079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a mouse model for thrombomodulin deficiency.
    Weiler H; Lindner V; Kerlin B; Isermann BH; Hendrickson SB; Cooley BC; Meh DA; Mosesson MW; Shworak NW; Post MJ; Conway EM; Ulfman LH; von Andrian UH; Weitz JI
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1531-7. PubMed ID: 11557684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist.
    Berny MA; White TC; Tucker EI; Bush-Pelc LA; Di Cera E; Gruber A; McCarty OJ
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):329-34. PubMed ID: 17962622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice.
    Bonetti NR; Jouppila AS; Saeedi Saravi SS; Cooley BC; Pasterk L; Liberale LL; Gobbato S; Lüscher TF; Camici GG; Lassila RP; Beer JH
    Thromb Res; 2023 Aug; 228():163-171. PubMed ID: 37331119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation.
    Wei HJ; Li YH; Shi GY; Liu SL; Chang PC; Kuo CH; Wu HL
    Cardiovasc Res; 2011 Nov; 92(2):317-27. PubMed ID: 21840881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II.
    He L; Giri TK; Vicente CP; Tollefsen DM
    Blood; 2008 Apr; 111(8):4118-25. PubMed ID: 18281504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the anticoagulant activity of thrombin mutant W215A/E217A.
    Gandhi PS; Page MJ; Chen Z; Bush-Pelc L; Di Cera E
    J Biol Chem; 2009 Sep; 284(36):24098-105. PubMed ID: 19586901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling of carotid arteries is associated with increased expression of thrombomodulin in a mouse transverse aortic constriction model.
    Li YH; Hsieh CY; Wang DL; Chung HC; Liu SL; Chao TH; Shi GY; Wu HL
    Thromb Haemost; 2007 Apr; 97(4):658-64. PubMed ID: 17393030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombomodulin plays an important role in arterial remodeling and neointima formation in mouse carotid ligation model.
    Li YH; Liu SL; Shi GY; Tseng GH; Liu PY; Wu HL
    Thromb Haemost; 2006 Jan; 95(1):128-33. PubMed ID: 16543971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet endothelial cell adhesion molecule targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and in vivo.
    Carnemolla R; Greineder CF; Chacko AM; Patel KR; Ding BS; Zaitsev S; Esmon CT; Muzykantov VR
    J Pharmacol Exp Ther; 2013 Nov; 347(2):339-45. PubMed ID: 23965383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of tPA significantly affects antithrombotic therapy by a GPIIb/IIIa antagonist, but not by a thrombin inhibitor in mice.
    Matsuno H; Kozawa O; Ueshima S; Matsuo O; Collen D; Uematsu T
    Thromb Haemost; 2000 Apr; 83(4):605-9. PubMed ID: 10780325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitronectin inhibits the thrombotic response to arterial injury in mice.
    Fay WP; Parker AC; Ansari MN; Zheng X; Ginsburg D
    Blood; 1999 Mar; 93(6):1825-30. PubMed ID: 10068653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery.
    Matsuno H; Kozawa O; Niwa M; Tanabe K; Ichimaru K; Takiguchi Y; Yokota M; Hayashi H; Uematsu T
    Thromb Haemost; 1998 Apr; 79(4):865-71. PubMed ID: 9569206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early loss of thrombomodulin expression impairs vein graft thromboresistance: implications for vein graft failure.
    Kim AY; Walinsky PL; Kolodgie FD; Bian C; Sperry JL; Deming CB; Peck EA; Shake JG; Ang GB; Sohn RH; Esmon CT; Virmani R; Stuart RS; Rade JJ
    Circ Res; 2002 Feb; 90(2):205-12. PubMed ID: 11834714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation.
    Ding BS; Hong N; Christofidou-Solomidou M; Gottstein C; Albelda SM; Cines DB; Fisher AB; Muzykantov VR
    Am J Respir Crit Care Med; 2009 Aug; 180(3):247-56. PubMed ID: 19342415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.